Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Dec;54(12):1075–1082. doi: 10.1136/thx.54.12.1075

Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients

P Hood 1, T Cotter 1, J Costello 1, A Sampson 1
PMCID: PMC1763762  PMID: 10567626

Abstract

BACKGROUND—The cysteinyl-leukotrienes (LTC4, LTD4, LTE4) are critical bronchoconstrictor and eosinophilotactic mediators in asthma while LTB4 is a potent neutrophil chemoattractant. Glucocorticosteroids are front line anti-inflammatory treatment for asthma but the evidence that they reduce leukotriene (LT) synthesis in vivo is poor.
METHODS—In a randomised, double blind, placebo controlled, crossover trial immunoassays were used to measure ex vivo synthesis of LTC4 and LTB4 by calcium ionophore stimulated blood leucocytes and bronchoalveolar lavage (BAL) cells of eight normal subjects and eight patients with mild allergic asthma 4-6 hours after intravenous administration of a single 100 mg dose of methylprednisolone.
RESULTS—Ionophore stimulated synthesis of LTC4 (but not LTB4) in blood granulocytes tended to be higher in asthmatic subjects (mean 9.7 ng/106 cells) than in normal subjects (4.2 ng/106 cells; p = 0.08) and intravenous methylprednisolone reduced synthesis of LTC4 (but not LTB4) to normal levels (2.9 ng/106 cells; 95% CI for the reduction 1.0 to 12.5 ng/106 cells; p = 0.03). In blood mononuclear cells methylprednisolone reduced LTC4 synthesis in asthmatic subjects from 1.26 to 0.79 ng/106 cells (95% CI for the reduction 0.26 to 0.79, p = 0.014) and tended to reduce LTC4 synthesis in normal subjects from 1.51 to 0.86 ng/106 cells (p = 0.08). Methylprednisolone also significantly reduced synthesis of LTB4 in mononuclear cells from both subject groups (p = 0.014). It had no effect on LT synthesis in BAL cells from either group nor on LT levels in BAL fluid.
CONCLUSIONS—Intravenous methylprednisolone can reduce synthesis of leukotrienes in blood granulocytes and mononuclear cells within six hours of a single intravenous dose.



Full Text

The Full Text of this article is available as a PDF (107.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balter M. S., Eschenbacher W. L., Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. Am Rev Respir Dis. 1988 Nov;138(5):1134–1142. doi: 10.1164/ajrccm/138.5.1134. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993 Dec;14(12):436–441. doi: 10.1016/0165-6147(93)90184-l. [DOI] [PubMed] [Google Scholar]
  3. Bruijnzeel P. L., Virchow J. C., Jr, Rihs S., Walker C., Verhagen J. Lack of increased numbers of low-density eosinophils in the circulation of asthmatic individuals. Clin Exp Allergy. 1993 Apr;23(4):261–269. doi: 10.1111/j.1365-2222.1993.tb00320.x. [DOI] [PubMed] [Google Scholar]
  4. Christie P. E., Barnes N. C. Leukotriene B4 and asthma. Thorax. 1996 Dec;51(12):1171–1173. doi: 10.1136/thx.51.12.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cowburn A. S., Holgate S. T., Sampson A. P. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J Immunol. 1999 Jul 1;163(1):456–465. [PubMed] [Google Scholar]
  6. De Caterina R., Sicari R., Giannessi D., Paggiaro P. L., Paoletti P., Lazzerini G., Bernini W., Solito E., Parente L. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol (1985) 1993 Dec;75(6):2368–2375. doi: 10.1152/jappl.1993.75.6.2368. [DOI] [PubMed] [Google Scholar]
  7. Dworski R., Fitzgerald G. A., Oates J. A., Sheller J. R. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):953–959. doi: 10.1164/ajrccm.149.4.8143061. [DOI] [PubMed] [Google Scholar]
  8. Goppelt-Struebe M., Schaefer D., Habenicht A. J. Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells. Br J Pharmacol. 1997 Oct;122(4):619–624. doi: 10.1038/sj.bjp.0701425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hay D. W., Torphy T. J., Undem B. J. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci. 1995 Sep;16(9):304–309. doi: 10.1016/s0165-6147(00)89059-8. [DOI] [PubMed] [Google Scholar]
  10. Holgate S. T., Bradding P., Sampson A. P. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol. 1996 Jul;98(1):1–13. doi: 10.1016/s0091-6749(96)70220-8. [DOI] [PubMed] [Google Scholar]
  11. Hoshiko S., Rådmark O., Samuelsson B. Characterization of the human 5-lipoxygenase gene promoter. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9073–9077. doi: 10.1073/pnas.87.23.9073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kennedy B. P., Diehl R. E., Boie Y., Adam M., Dixon R. A. Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP). J Biol Chem. 1991 May 5;266(13):8511–8516. [PubMed] [Google Scholar]
  13. Laitinen L. A., Laitinen A., Haahtela T., Vilkka V., Spur B. W., Lee T. H. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet. 1993 Apr 17;341(8851):989–990. doi: 10.1016/0140-6736(93)91073-u. [DOI] [PubMed] [Google Scholar]
  14. Leff J. A., Busse W. W., Pearlman D., Bronsky E. A., Kemp J., Hendeles L., Dockhorn R., Kundu S., Zhang J., Seidenberg B. C. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med. 1998 Jul 16;339(3):147–152. doi: 10.1056/NEJM199807163390302. [DOI] [PubMed] [Google Scholar]
  15. Littenberg B., Gluck E. H. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986 Jan 16;314(3):150–152. doi: 10.1056/NEJM198601163140304. [DOI] [PubMed] [Google Scholar]
  16. Manso G., Baker A. J., Taylor I. K., Fuller R. W. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Eur Respir J. 1992 Jun;5(6):712–716. [PubMed] [Google Scholar]
  17. O'Shaughnessy K. M., Wellings R., Gillies B., Fuller R. W. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1472–1476. doi: 10.1164/ajrccm/147.6_Pt_1.1472. [DOI] [PubMed] [Google Scholar]
  18. Peers S. H., Flower R. J. The role of lipocortin in corticosteroid actions. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S18–S21. [PubMed] [Google Scholar]
  19. Peters-Golden M., Thebert P. Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages. Am Rev Respir Dis. 1987 May;135(5):1020–1026. doi: 10.1164/arrd.1987.135.5.1020. [DOI] [PubMed] [Google Scholar]
  20. Peters S. P., Naclerio R. M., Schleimer R. P., MacGlashan D. W., Jr, Pipkorn U., Lichtenstein L. M. The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986;50 (Suppl 2):116–122. doi: 10.1159/000195109. [DOI] [PubMed] [Google Scholar]
  21. Pouliot M., McDonald P. P., Borgeat P., McColl S. R. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med. 1994 Apr 1;179(4):1225–1232. doi: 10.1084/jem.179.4.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Restrick L. J., Sampson A. P., Piper P. J., Costello J. F. Inulin as a marker of dilution of bronchoalveolar lavage in asthmatic and normal subjects. Am J Respir Crit Care Med. 1995 Apr;151(4):1211–1217. doi: 10.1164/ajrccm.151.4.7697255. [DOI] [PubMed] [Google Scholar]
  23. Restrick L. J., Sampson A. P., Piper P. J., Costello J. F. Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma. Thorax. 1995 Jan;50(1):67–73. doi: 10.1136/thx.50.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Riddick C. A., Ring W. L., Baker J. R., Hodulik C. R., Bigby T. D. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur J Biochem. 1997 May 15;246(1):112–118. doi: 10.1111/j.1432-1033.1997.00112.x. [DOI] [PubMed] [Google Scholar]
  25. Sampson A. P., Thomas R. U., Costello J. F., Piper P. J. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol. 1992 Apr;33(4):423–430. doi: 10.1111/j.1365-2125.1992.tb04062.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sampson S. E., Costello J. F., Sampson A. P. The effect of inhaled leukotriene B4 in normal and in asthmatic subjects. Am J Respir Crit Care Med. 1997 May;155(5):1789–1792. doi: 10.1164/ajrccm.155.5.9154893. [DOI] [PubMed] [Google Scholar]
  27. Sano A., Muñoz N. M., Sano H., Choi J., Zhu X., Jacobs B., Leff A. R. Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils. Am J Respir Crit Care Med. 1999 Jun;159(6):1903–1909. doi: 10.1164/ajrccm.159.6.9810005. [DOI] [PubMed] [Google Scholar]
  28. Schleimer R. P., Freeland H. S., Peters S. P., Brown K. E., Derse C. P. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther. 1989 Aug;250(2):598–605. [PubMed] [Google Scholar]
  29. Sebaldt R. J., Sheller J. R., Oates J. A., Roberts L. J., 2nd, FitzGerald G. A. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6974–6978. doi: 10.1073/pnas.87.18.6974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Storr J., Barrell E., Barry W., Lenney W., Hatcher G. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987 Apr 18;1(8538):879–882. doi: 10.1016/s0140-6736(87)92857-1. [DOI] [PubMed] [Google Scholar]
  31. Takafuji S., Bischoff S. C., De Weck A. L., Dahinden C. A. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol. 1991 Dec 1;147(11):3855–3861. [PubMed] [Google Scholar]
  32. Taylor G. W., Taylor I., Black P., Maltby N. H., Turner N., Fuller R. W., Dollery C. T. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1989 Mar 18;1(8638):584–588. doi: 10.1016/s0140-6736(89)91611-5. [DOI] [PubMed] [Google Scholar]
  33. Weller P. F., Lee C. W., Foster D. W., Corey E. J., Austen K. F., Lewis R. A. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7626–7630. doi: 10.1073/pnas.80.24.7626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wenzel S. E., Larsen G. L., Johnston K., Voelkel N. F., Westcott J. Y. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis. 1990 Jul;142(1):112–119. doi: 10.1164/ajrccm/142.1.112. [DOI] [PubMed] [Google Scholar]
  35. Wenzel S. E., Trudeau J. B., Westcott J. Y., Beam W. R., Martin R. J. Single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEV1. J Allergy Clin Immunol. 1994 Nov;94(5):870–881. doi: 10.1016/0091-6749(94)90155-4. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES